Review article: Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients

Journal of Surgical Oncology

Volumn 76, Issue 2, 2001, Pages 144-156

  Noguchi, Masakuni ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

ALBUMIN TC 99M COLLOID; ANTIMONY TECHNETIUM SULFIDE TC 99M; CHARCOAL; DISULFINE BLUE; DYE; INDIGO CARMINE; INDOCYANINE GREEN; ISOSULFAN BLUE; SERUM ALBUMIN TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; TECHNETIUM TIN COLLOID TC 99M; TRACER;

AXILLARY LYMPH NODE; BREAST AREOLA; BREAST CANCER; CANCER CYTODIAGNOSIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG ADMINISTRATION; FROZEN SECTION; HISTORY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM; LYMPHOSCINTIGRAPHY; MOLECULAR BIOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; TECHNIQUE; VALIDATION PROCESS; BREAST; BREAST TUMOR; CANCER STAGING; FEMALE; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SURVIVAL;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 0035107895     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200102)76:2<144::AID-JSO1028>3.0.CO;2-H     Document Type: Review

References (101)

1. Total axillary lymphadenectomy in the management of breast cancer
2. The axilla; not a no-go zone
3. The role of axillary lymph node dissection in breast cancer management
4. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
5. Manchester regional breast study - 5 and 10 years results
6. Cancer Research Campaign (King's/Cambridge) trial for early breast cancer. A detailed uptake at the tenth year
7. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer
8. Breast conservation is a safe method in patients with small cancer of the breast. Long term results of three randomized trials on 1973 patients
9. Risk of lymphedema following the treatment of breast cancer
10. Assessment of morbidity from complete axillary dissection
11. Diagnosis of axillary lymph node metastases in patients with breast cancer
12. An approach for the treatment of penile carcinoma
13. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
14. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
15. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer
16. Sentinel lymph node mapping in breast cancer
17. Anatomy of the mammary gland
18. The lymphatics of the breast
19. Lymphatic drainage of the breast demonstrated by vital dye staining and radiography
20. Direct lymphography of the breast
21. Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept
22. Technical details of intraoperative lymphatic mapping for early stage melanoma
23. Gamma-probe guided localization of lymph nodes
24. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
25. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
26. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
27. The sentinel node in breast cancer. A multicenter validation study
28. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques
29. Credentialing for breast lymphatic mapping: How many cases are enough?
30. Mapping a pathway for axillary staging. A personal perspective on the current status of sentinel lymph node dissection for breast cancer
31. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
32. The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer
33. Lymphoscintigraphy and the intraoperative gamma probe
34. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
35. Sentinel lymph node involvement - A predictor for axillary node status with breast cancer - Has the time come?
36. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society
37. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
38. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
39. Efficacy and significance of sentinel lymph node identification with technetium-99m-labeled tin colloids for breast cancer
40. Optimized sentinel node scintigraphy in breast cancer
41. Sentinel lymphadenectomy in breast cancer: Identification of sentinel lymph node and detection of metastases
42. Quantitative lymphoscintigraphy. I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits
43. Radiopharmaceuticals in sentinel lymph-node detection. An overview
44. Gamma probe-guided sentinel node biopsy - Optimal timing for injection
45. Sentinel lymph node detection and imaging
46. Gamma probe guided sentinel node biopsy in breast cancer
47. Development of sentinel node targeting technique in breast cancer patients
48. Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered
49. Extra-axillary sentinel lymph nodes in breast cancer
50. Mammary lymphoscintigraphy in breast cancer
51. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
52. Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients. Efficacy of filtered technetium 99m sulfur colloid with overnight migration time
53. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
54. Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer
55. Sentinel-node biopsy in breast cancer
56. Lymphatic mapping and sentinel lymph node biopsy in breast cancer
57. Sentinel node localization in breast cancer
58. Lymphatic mapping: A technique providing accurate staging for breast cancer
59. Subareolar versus peritumoral injection for location of the sentinel lymph node
60. Intradermal blue dye to identify sentinel lymph node in breast cancer
61. Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies
62. Sentinel-lymph node biopsy for breast cancer - Not yet the standard of care
63. Improved axillary staging of breast cancer with sentinel lymphadenectomy
64. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node
65. Pathological investigation of sentinel lymph nodes
66. Sentinel node biopsy in the staging of breast cancer
67. Serial sectioning of sentinel nodes in patients with breast cancer: A pilot study
68. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
69. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma
70. Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients
71. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
72. The use of touch preparation (tissue imprint) in the rapid intraoperative diagnosis of metastatic lymph node disease in cancer staging procedures
73. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer
74. Reliability of intra-operative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer
75. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase - Polymerase chain reaction
76. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
77. Discontinuous or "skip" metastases in breast carcinoma: Analysis of 1228 axillary dissections
78. Patterns of axillary lymph node metastasis in breast cancer
79. Distribution of axillary node metastases by level of invasion: An analysis of 539 cases
80. Inefficacy of internal mammary nodes dissection in breast cancer surgery
81. Comment on "Improved axillary staging of breast cancer with sentinel lymphadenectomy"
82. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes
83. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer
84. Internal mammary chain sentinel lymph node identification in breast cancer
85. Sentinel node biopsy in breast cancer
86. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy
87. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
88. Sentinel lymph node biopsy for breast cancer: The role of previous biopsy on patient eligibility
89. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabelled dextran
90. Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulphan blue dye
91. Lymphoscintigraphy: Radiopharmaceutical selection and methods
92. Intraoperative lymphatic mapping and sentinel lymphadenectomy: Community standard care or clinical investigation?
93. Lymphatic mapping in the treatment of breast cancer
94. Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer
95. Sentinel node biopsy in breast cancer. A promising technique, but it should not be introduced without proper trials
96. Four large studies aim to resolve sentinel node debate
97. The sentinel node for staging breast cancer: Current review
98. Comparison of survival rates between American and Japanese patients with breast cancer
99. Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Finding from National Surgical Adjuvant Breast and Bowel Project B-25